Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

First Of Its Kind Blood Test Accurately Predicts Preterm Birth Risk

By LabMedica International staff writers
Posted on 17 Jan 2025

Preterm birth is one of the leading causes of childhood mortality worldwide. More...

The World Health Organization reports that over 15 million babies are born prematurely each year, with more than a million of them not surviving. Approximately 70% of preterm births occur spontaneously, without a medical indication. Black mothers are also twice as likely to experience preterm birth compared to White mothers, although the reasons for this disparity remain unclear. Now, a groundbreaking blood test has been developed that may predict the risk of preterm birth early in pregnancy.

Researchers at The Ohio State University (Columbus, OH, USA) developed this new blood test after studying various risk factors for preterm birth, including stressors such as early life adversity and experiences of racial discrimination. They discovered that persistent stress, poor sleep, depression, and anxiety can subtly alter the functioning of the immune system over time. These changes in immune function can be detected with a simple blood test, requiring less than a teaspoon of blood. Initial tests of the blood test show promising potential, with the ability to predict the risk of preterm birth with accuracy as high as 97.5%.

The researchers suggest that the test could be incorporated into the "prenatal battery," a set of screenings designed to help clinicians identify factors that may increase a patient's risk of preterm birth, allowing for early interventions before any symptoms appear. The team is now working to conduct a larger and more comprehensive study to ensure the test's accuracy in diverse patient populations. They are also exploring treatments that could "reset" the immune system’s responses to normal levels to further reduce the risk of preterm birth.

“We’re essentially trying to create this ‘crystal ball’ of future events. We are truly producing a future likely scenario early in pregnancy. And so, if the body’s not responding in the right way, we can see that,” said Shannon Gillespie, PhD, RN, FAAN, assistant professor at Ohio State’s College of Nursing. “It should feel as simple as a test for anemia. So things that can be available for everyone that’s interested.”


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.